API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/endo-launches-bivalirudin-injection-in-ready-to-use-vials-301880137.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210031
https://www.forbes.com/sites/annemarieknott/2019/03/11/the-medicines-company-innovating-innovation/#726b9aa35ae1
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nod-for-aurobindo-pharma-to-make-market-bivalirudin-injection/articleshow/65196682.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205962
https://www.drugdeliverybusiness.com/mylan-launches-generic-drug-delivery-patch-for-dementia-patients/
https://www.biospectrumasia.com/news/34/11108/mylan-announces-us-launch-of-bivalirudin-for-injection.html
https://www.prnewswire.com/news-releases/mylan-launches-generic-angiomax-injection-300667911.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202471
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204876
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202471
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091468
https://www.statnews.com/pharmalot/2016/05/05/appeals-court-patent-drug-makers/
http://cphi-online.com/eagle-pharmaceuticals-receives-complete-response-news039629.html
http://www.reuters.com/article/us-eagle-pharms-fda-idUSKCN0WK18V
http://www.fdanews.com/articles/172061-federal-circuit-revokes-the-medicines-cos-angiomax-patents
http://manufacturing.pharmaceutical-business-review.com/news/the-medicines-company-authorizes-generic-launch-of-angiomax-100715-4620497?utm_term=Pharma&utm_source=PBR&utm_medium=twitter
http://www.businesswire.com/news/home/20150702005697/en/Federal-Circuit-Rules-Medicines-Company-Angiomax%C2%AE-bivalirudin#.VZZCiRuqqkp
http://www.fiercebiotech.com/story/after-phiii-odyssey-fda-finally-gives-medicines-co-thumbs-cangrelor/2015-04-13
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-settles-angiomax-litigation-with-the-medicines-company/articleshow/46773726.cms